(Q43801262)

26 November 2017

Spontaneous tumor necrosis factor production in Kawasaki disease (English)

1 reference

26 November 2017

Lang BA

1

1 reference

26 November 2017

Silverman ED

series ordinal

2

1 reference

26 November 2017

Laxer RM

series ordinal

3

1 reference

26 November 2017

Lau AS

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 December 1989

1 reference

The Journal of Pediatrics

26 November 2017

1 reference

26 November 2017

115

1 reference

26 November 2017

6

1 reference

26 November 2017

939-943

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

26 November 2017

1 reference

Immunoregulatory abnormalities in mucocutaneous lymph node syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

Enhanced endothelial cell proliferation in acute Kawasaki disease (muco-cutaneous lymph node syndrome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. A skin biopsy study of 27 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

The Recruitment of Leukocytes and their Interaction with the Vessel Wall: The Role of Interleukin-1 and Tumor Necrosis Factor

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980746-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(89)80746-2

1 reference

26 November 2017

1 reference